These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2160444)
1. No-carrier-added (NCA) N-(3-[18F]fluoropropyl)-N-norbuprenorphine and N-(3-[18F]fluoropropyl)-N-nordiprenorphine--synthesis, anatomical distribution in mice and rats, and tomographic studies in a baboon. Bai LQ; Teng RR; Shiue CY; Wolf AP; Dewey SL; Holland MJ; Simon EJ Int J Rad Appl Instrum B; 1990; 17(2):217-27. PubMed ID: 2160444 [TBL] [Abstract][Full Text] [Related]
2. N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography. Chesis PL; Hwang DR; Welch MJ J Med Chem; 1990 May; 33(5):1482-90. PubMed ID: 2158564 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the brain uptake of N-(cyclopropyl[11C]methyl)norbuprenorphine ([11C]buprenorphine) and N-(cyclopropyl[11C]methyl)nordiprenorphine ([11C]diprenorphine) in baboon using PET. Shiue CY; Bai LQ; Teng RR; Arnett CD; Dewey SL; Wolf AP; McPherson DW; Fowler JS; Logan J; Holland MJ Int J Rad Appl Instrum B; 1991; 18(3):281-8. PubMed ID: 2071440 [TBL] [Abstract][Full Text] [Related]
4. No-carrier-added (NCA) (+/-)-N-(3-[18F]fluoropropyl)-N-normetazocine-synthesis and PET studies in a baboon. Shiue CY; Teng RR; Bai LQ; Wolf AP; Arnett CD; Simon EJ Int J Rad Appl Instrum B; 1987; 14(2):119-22. PubMed ID: 3496324 [TBL] [Abstract][Full Text] [Related]
5. No-carrier-added N-(3-[18F]fluoropropyl)spiroperidol: biodistribution in mice and tomographic studies in a baboon. Shiue CY; Bai LQ; Teng RR; Arnett CD; Wolf AP J Nucl Med; 1987 Jul; 28(7):1164-70. PubMed ID: 3496434 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of three structurally related ¹⁸F-labeled orvinols of different intrinsic activities: 6-O-[¹⁸F]fluoroethyl-diprenorphine ([¹⁸F]FDPN), 6-O-[¹⁸F]fluoroethyl-buprenorphine ([¹⁸F]FBPN), and 6-O-[¹⁸F]fluoroethyl-phenethyl-orvinol ([¹⁸F]FPEO). Schoultz BW; Hjørnevik T; Reed BJ; Marton J; Coello CS; Willoch F; Henriksen G J Med Chem; 2014 Jun; 57(12):5464-9. PubMed ID: 24933507 [TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey. Shiue CY; Shiue GG; Rysavy JA; Pleus RC; Huang H; Bai LQ; Cornish KG; Sunderland JJ; Frick MP Nucl Med Biol; 1993 Nov; 20(8):973-81. PubMed ID: 8298577 [TBL] [Abstract][Full Text] [Related]
9. The utility of 1-[18F]fluoro-3-iodopropane for the synthesis of certain dopamine D-1 and benzodiazepine receptor radioligands. Teng RR; Bai LQ; Shiue CY; Dewey SL; Arnett CD; Wolf AP; Hitzemann RJ Int J Rad Appl Instrum B; 1990; 17(8):811-7. PubMed ID: 2079428 [TBL] [Abstract][Full Text] [Related]
10. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors. Yang ZY; Perry B; Mukherjee J Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, tissue distribution in rats and PET studies in baboon brain of no-carrier-added [18F]RU 52461: in vivo evaluation as a brain glucocorticoid receptor radioligand. Dasilva JN; Crouzel C; Stulzaft O; Khalili-Varasteh M; Hantraye P Int J Rad Appl Instrum B; 1992 Feb; 19(2):167-73. PubMed ID: 1601670 [TBL] [Abstract][Full Text] [Related]
12. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640 [TBL] [Abstract][Full Text] [Related]
13. 6-O-(2-[18F]fluoroethyl)-6-O-desmethyldiprenorphine ([18F]DPN): synthesis, biologic evaluation, and comparison with [11C]DPN in humans. Wester HJ; Willoch F; Tölle TR; Munz F; Herz M; Oye I; Schadrack J; Schwaiger M; Bartenstein P J Nucl Med; 2000 Jul; 41(7):1279-86. PubMed ID: 10914922 [TBL] [Abstract][Full Text] [Related]
14. Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain. Galynker I; Schlyer DJ; Dewey SL; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Ferrieri RA; Holland MJ; Brodie J; Simon E; Wolf AP Nucl Med Biol; 1996 Apr; 23(3):325-31. PubMed ID: 8782244 [TBL] [Abstract][Full Text] [Related]
15. Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons. Shiue CY; Vallabhahosula S; Wolf AP; Dewey SL; Fowler JS; Schlyer DJ; Arnett CD; Zhou YG Nucl Med Biol; 1997 Feb; 24(2):145-50. PubMed ID: 9089707 [TBL] [Abstract][Full Text] [Related]
16. Development of fluorine-18-labeled 5-HT1A antagonists. Lang L; Jagoda E; Schmall B; Vuong BK; Adams HR; Nelson DL; Carson RE; Eckelman WC J Med Chem; 1999 May; 42(9):1576-86. PubMed ID: 10229627 [TBL] [Abstract][Full Text] [Related]
17. Autoradiographic and SPECT imaging of cerebral opioid receptors with an iodine-123 labeled analogue of diprenorphine. Lever JR; Ilgìn N; Musachio JL; Scheffel U; Finley PA; Flesher JE; Natarajan TK; Wagner HN; Frost JJ Synapse; 1998 Jun; 29(2):172-82. PubMed ID: 9593107 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies. Mathis CA; Bishop JE; Gerdes JM; Whitney JM; Brennan KM; Jagust WJ Int J Rad Appl Instrum B; 1992 Jul; 19(5):571-88. PubMed ID: 1399687 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of (+/-)-[18F]BMY 14802, its enantiomers and their anatomical distributions in rodents. Shiue CY; Bai LQ; Shiue GG; Rysavy JA; Pleus RC; Hui H; Frick MP; Catt JD Nucl Med Biol; 1993 Jul; 20(5):625-30. PubMed ID: 8358348 [TBL] [Abstract][Full Text] [Related]